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Toward a Better Understanding of...
Characterization of Biotinylated Molecules 
in Triple-Transgenic Alzheimer’s Mouse Model
Evan Garden
Mentor: David Brody
Alzheimer’s Disease (AD) is the most common neurodegenerative disease in humans, 
affecting approximately 11% of people aged 65 years and older. While AD pathology 
is characterized by amyloid-beta (Aβ) peptide aggregation into insoluble plaques, 
numerous studies have implicated water-soluble Aβ oligomers as the most toxic form of 
Aβ. To date, the structure and mechanism of toxicity of soluble Aβ oligomers remains 
unclear due to an inability to accurately purify and quantify soluble Aβ oligomers from 
human AD patient and animal model brains. In particular, several methods utilize 
the interaction between biotin and streptavidin to purify and quantify Aβoligomers. 
However, studies have shown endogenous biotin-containing molecules occur in many 
regions of the central nervous system. Thus, the reliability of these techniques may be 
compromised if any proteins—including Aβ oligomers—are endogenously biotinylated.
In this experiment, soluble lysates from the forebrains of triple transgenic AD (3xTg-
AD) mouse models were prepared and treated with streptavidin-conjugated agarose 
beads and free avidin protein, followed by streptavidin-conjugated agarose beads. 
Samples were separated using size-exclusion chromatography (SEC), and the abundance 
of biotinylated molecules and Aβ species—both monomeric and oligomeric—were 
assessed through direct and indirect enzymelinked immunosorbent assays (ELISA) for all 
groups. We found that treatment with streptavidinconjugated agarose beads resulted in 
the complete loss of immunoreactivity previously attributed to Aβ oligomers. Therefore, 
it raises the intriguing possibility that Aβ oligomers derived from the 3xTg-AD mouse 
model are endogenously biotinylated. Additional analysis via mass spectrometry will be 
performed to confirm the biotinylation of Aβ oligomers in 3xTg-AD mouse model and 
human AD patient brains.
